185 related articles for article (PubMed ID: 38078724)
1. The
Williams JT; Giletto M; Haiderer ER; Aleiwi B; Krieger-Burke T; Ellsworth E; Abramovitch RB
Microbiol Spectr; 2024 Jan; 12(1):e0367723. PubMed ID: 38078724
[TBL] [Abstract][Full Text] [Related]
2. A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.
Park J; Kwak N; Chae JC; Yoon EJ; Jeong SH
Microbiol Spectr; 2023 Aug; 11(4):e0160623. PubMed ID: 37378523
[TBL] [Abstract][Full Text] [Related]
3. Transition between Mycobacterium tuberculosis and nontuberculous mycobacteria in recurrent "tuberculosis" patients.
Li Q; Li H; An J; Zhang X; Wang W; Wang Y; Xue Z; Li S; Pang Y
Eur J Clin Microbiol Infect Dis; 2022 Aug; 41(8):1127-1132. PubMed ID: 35882723
[TBL] [Abstract][Full Text] [Related]
4. Genomic and phenotypic characterization of
Sous C; Frigui W; Pawlik A; Sayes F; Ma L; Cokelaer T; Brosch R
Microbiol Spectr; 2024 Jun; 12(6):e0412623. PubMed ID: 38700329
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting
Shin S; Yoo IY; Shim HJ; Kang OK; Jhun BW; Koh WJ; Huh HJ; Lee NY
Ann Lab Med; 2020 Mar; 40(2):169-173. PubMed ID: 31650734
[TBL] [Abstract][Full Text] [Related]
6. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
[TBL] [Abstract][Full Text] [Related]
7. Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in
Raynaud C; Daher W; Johansen MD; Roquet-Banères F; Blaise M; Onajole OK; Kozikowski AP; Herrmann JL; Dziadek J; Gobis K; Kremer L
ACS Infect Dis; 2020 Feb; 6(2):324-337. PubMed ID: 31860799
[TBL] [Abstract][Full Text] [Related]
8. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.
Gopalaswamy R; Shanmugam S; Mondal R; Subbian S
J Biomed Sci; 2020 Jun; 27(1):74. PubMed ID: 32552732
[TBL] [Abstract][Full Text] [Related]
9. Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease.
Raju RM; Raju SM; Zhao Y; Rubin EJ
Emerg Infect Dis; 2016 Mar; 22(3):365-9. PubMed ID: 26886068
[TBL] [Abstract][Full Text] [Related]
10. Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessus.
Yang JJ; Goff A; Wild DJ; Ding Y; Annis A; Kerber R; Foote B; Passi A; Duerksen JL; London S; Puhl AC; Lane TR; Braunstein M; Waddell SJ; Ekins S
Tuberculosis (Edinb); 2024 May; 146():102500. PubMed ID: 38432118
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India.
Das S; Mishra B; Mohapatra PR; Preetam C; Rath S
Int J Mycobacteriol; 2022; 11(2):167-174. PubMed ID: 35775549
[TBL] [Abstract][Full Text] [Related]
12. MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections.
Sethiya JP; Sowards MA; Jackson M; North EJ
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867307
[TBL] [Abstract][Full Text] [Related]
13. CapitalBio Mycobacterium real-time polymerase chain reaction detection test: Rapid diagnosis of Mycobacterium tuberculosis and nontuberculous mycobacterial infection.
Shen Y; Fang L; Xu X; Ye B; Yu G
Int J Infect Dis; 2020 Sep; 98():1-5. PubMed ID: 32553719
[TBL] [Abstract][Full Text] [Related]
14. Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: public health and diagnostic implications for control programmes.
Hoza AS; Mfinanga SG; Rodloff AC; Moser I; König B
BMC Res Notes; 2016 Feb; 9():109. PubMed ID: 26887928
[TBL] [Abstract][Full Text] [Related]
15. Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
Aragaw WW; Roubert C; Fontaine E; Lagrange S; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0140021. PubMed ID: 34723632
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China.
Lan R; Yang C; Lan L; Ou J; Qiao K; Liu F; Gao Q
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1669-75. PubMed ID: 22118176
[TBL] [Abstract][Full Text] [Related]
17. Varying clinical presentations of nontuberculous mycobacterial disease : Similar to but different from tuberculosis.
Shinohara T; Morizumi S; Sumitomo K
J Med Invest; 2021; 68(3.4):220-227. PubMed ID: 34759134
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana.
Bjerrum S; Oliver-Commey J; Kenu E; Lartey M; Newman MJ; Addo KK; Hilleman D; Andersen AB; Johansen IS
Trop Med Int Health; 2016 Sep; 21(9):1181-90. PubMed ID: 27383726
[TBL] [Abstract][Full Text] [Related]
19. Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.
Addo KK; Addo SO; Mensah GI; Mosi L; Bonsu FA
BMC Infect Dis; 2017 Dec; 17(1):743. PubMed ID: 29197331
[TBL] [Abstract][Full Text] [Related]
20. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.
Yoon HJ; Choi HY; Ki M
BMC Infect Dis; 2017 Jun; 17(1):432. PubMed ID: 28619015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]